2186.HK
2186.HK
BMG570071099
LUYE PHARMA
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 6.308.374.000 6.061.441.000
4.1%
Cost of Revenue 2.145.791.000 2.017.214.000
6.4%
Gross Profit 4.162.583.000 4.044.227.000
2.9%
2.906.959.000 2.753.172.000
5.6%
Operating Income 1.255.624.000 1.291.055.000
2.7%
Pretax Income 944.637.000 839.219.000
12.6%
Net Income Common Stockholders 618.747.000 471.886.000
31.1%
-- --
--
-- --
--
ende